Friday 6 November 2026 Export HIMS’s income statement to Excel — free account

Hims & Hers Health, Inc.

HIMS Healthcare Drug Manufacturers Specialty & Generic

Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.

Revenue: +38.3%
EPS: −294.7%
Free cash flow: +5.09%
Total debt: +40.8%

Quarter to June 2026, against a year earlier

25.50 1.44 +5.99%

Follow HIMS

Alert me

Market cap: $5.6B
P/E: 0.0×
Fwd P/E: −49.4×
Dividend yield: —
F-score: 4/9
Altman Z: 4.10
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Hims & Hers Health, Inc. (HIMS) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Hims & Hers Health, Inc. (HIMS) trades at a P/B ratio of 17.2×. Over the past ten years it has ranged from 0.0× (March 2021) to 5,959× (September 2019); the current reading is higher than 76% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 1.8× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/HIMS/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Hims &amp; Hers Health, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/HIMS/metrics/pb-ratio">Hims &amp; Hers Health, Inc. (HIMS) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	13.5×	23.29%
FY2024	11.0×	86.72%
FY2023	5.9×	41.48%
FY2022	4.1×	10.04%
FY2022	3.8×	3.05%
FY2021	3.7×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2020	0.3×	0.00%
FY2019	0.3×	—

Period	P/B ratio	Change
Jun 2026	24.8×	133.33%
Mar 2026	10.6×	(21.31%)
Dec 2025	13.5×	(38.89%)
Sep 2025	22.1×	11.17%
22 more quarters	Free account

Against its own ten years

Low 0.0× High 5,959×

Ten-year median 8.1×

Current reading's percentile 75

Company	P/B ratio
SUPN Indivior Pharmaceuticals Inc. compare	n/m
RDY Dr. Reddy's Laboratories Ltd compare	3.0×
ALKS Alkermes plc compare	4.0×
LNTH Lantheus Holdings, Inc. compare	4.9×
KNSA Kiniksa Pharmaceuticals International, plc compare	9.7×
AMLX Amylyx Pharmaceuticals, Inc. compare	12.9×
HIMS Hims & Hers Health, Inc.	17.2×
LQDA Liquidia Corporation compare	20.4×
AMRX AMNEAL PHARMACEUTICALS, INC. compare	59.5×
Drug Manufacturers Specialty & Generic industry median	1.8×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Hims & Hers Health, Inc. (HIMS) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on HIMS

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on HIMS

Stockrow Weekly